Line 425: | Line 425: | ||
border-radius: 5px; | border-radius: 5px; | ||
background-clip: padding-box; | background-clip: padding-box; | ||
− | padding:0 | + | padding:0 10px 10px 10px; |
min-height:300px; | min-height:300px; | ||
min-width:200px | min-width:200px | ||
Line 451: | Line 451: | ||
border-radius: 5px; | border-radius: 5px; | ||
background-clip: padding-box; | background-clip: padding-box; | ||
+ | padding:0 10px 10px 10px; | ||
min-height:300px; | min-height:300px; | ||
min-width:200px | min-width:200px |
Revision as of 03:43, 9 October 2017
Our Key Goals
The aim of the USYD iGEM 2017 team was to address the problem of insulin inaccessibility. The design of our insulin, and its means of expression, needed to look at five key characteristics: